Understanding the NHS Pathway#

Access to NHS-funded bottom surgery requires navigating a multi-year process through Gender Identity Clinics that are fundamentally overwhelmed. The pathway begins with a GP or self-referral to one of the NHS-commissioned GICs, where patients currently face extraordinary waits simply to be seen (NHS England, 2024).

The Laurels clinic in Exeter holds the longest wait in England at eight years and six months, currently booking patients referred in June 2017 (Gender Construction Kit, 2025). Belfast's Brackenburn Clinic in Northern Ireland shows eight years and two months, while Glasgow Sandyford's projection—based on current throughput against demand—suggests a theoretical 224-year wait (Scottish Government, 2024). Even the "shortest" wait at NHS Nottingham runs at approximately two years and nine months. The Welsh Gender Service offers a relatively shorter twenty-month wait for initial appointment, though surgery still requires referral through the four-nations contract managed by NHS England (NHS Wales, 2024).

Once seen, patients must satisfy criteria substantially stricter than international WPATH Standards of Care recommend. While WPATH SOC8 requires only six months of hormone therapy and has eliminated mandatory social transition requirements, NHS England maintains requirements of twelve continuous months of hormone therapy plus twelve continuous months living in the patient's gender role (Coleman et al., 2022; NHS England, 2024). Where WPATH now requires a single letter from any qualified healthcare professional, NHS England demands two letters for genital surgery, with at least one from a registered medical practitioner with gender dysphoria expertise. The second letter must come from a professional not directly involved in the patient's care.

The Assessment Process#

NHS assessment for gender-affirming surgery follows a structured but time-consuming pathway. After the initial years-long wait for a first GIC appointment, patients undergo a series of assessments to confirm gender dysphoria diagnosis and evaluate readiness for various interventions (NHS England, 2024).

The assessment process typically involves multiple appointments over twelve to eighteen months following that first appointment. During this period, clinicians evaluate psychological stability, capacity to consent, understanding of surgical options and outcomes, social circumstances and support systems, and compliance with hormone therapy if applicable. For genital surgery specifically, the process requires documentation from two independent assessors who have each met with the patient at least once (NHS England, 2024).

The twelve-month "real life experience" requirement reflects an approach that WPATH abandoned in its 2022 Standards of Care revision. The NHS specification explicitly states that this requirement is not about "qualifying for surgery" but rather "preparing and supporting the individual to cope with the profound personal and social consequences"—language that implies patients require protection from their own decisions (NHS England, 2024). This paternalistic framing contrasts sharply with informed consent models that center patient autonomy.

Hormone Therapy Through the NHS#

Hormone therapy is typically initiated by Gender Identity Clinics following assessment, though the twelve-month requirement for genital surgery means most patients will have been on hormones long before reaching surgical eligibility. Shared care arrangements with GPs are supposed to transfer ongoing hormone prescribing to primary care after initial titration by specialists, reducing the burden on GICs and improving patient access (NHS England, 2024).

In practice, shared care has become increasingly unreliable. The Royal College of General Practitioners' October 2024 position statement acknowledges GP roles in shared care while noting that gender identity "does not fall within GP remit," leaving patients in a referral grey zone (RCGP, 2024). Many GP practices explicitly decline shared care arrangements, citing concerns about their competence to prescribe hormones they have not initiated. This leaves patients dependent on GIC appointments for ongoing prescriptions—appointments that may be scheduled months apart due to capacity constraints.

The Cass Review's characterisation of the evidence base for gender-affirming care as "insufficient," while formally addressing only children and young people's services, has been cited by GPs withdrawing from hormone prescribing for adult patients (Cass, 2024). The December 2025 Levy Review documented these knock-on effects, finding many GPs "withdrawing from shared care arrangements" and patients "self-sourcing hormones from high-risk sources" due to delays and access barriers (Levy, 2025).

Surgical Commissioning and Available Procedures#

All bottom surgery for UK patients—regardless of nation—flows through a single four-nations contract managed by NHS England. This creates a single point of potential failure, as demonstrated when St Peter's Andrology Centre was decommissioned in March 2020, leaving an eighteen-month gap with no NHS provider for phalloplasty or metoidioplasty until New Victoria Hospital was appointed in September 2021 (TransActual, 2023).

NHS-Approved Surgical Centres#

Current NHS-approved surgical centres for feminising procedures include Chelsea and Westminster Hospital NHS Foundation Trust (newly commissioned), Parkside Hospital in Wimbledon, Nuffield Health Brighton, and St George's University Hospital (NHS England, 2024). Miss Tina Rashid serves as National Clinical Lead for Gender Surgery and the primary surgeon for vaginoplasty, vulvoplasty, and peritoneal/bowel vaginoplasty techniques. For masculinising procedures, Chelsea and Westminster and New Victoria Hospital in London handle metoidioplasty and phalloplasty referrals.

The Gender Dysphoria National Referral Support Service (GDNRSS) coordinates all four-nations surgical referrals, processing referrals from NHS GICs rather than directly from patients or private providers (NHS England, 2024). Contact the GDNRSS at 0800 055 6607 for referral status inquiries.

Covered Procedures#

The range of NHS-commissioned procedures covers vaginoplasty using penile inversion and peno-scrotal flap techniques, vulvoplasty, bilateral orchiectomy, clitoroplasty, phalloplasty using multiple techniques including radial forearm and anterolateral thigh flap, metoidioplasty with or without urethroplasty and scrotoplasty, and hysterectomy with salpingo-oophorectomy when performed alongside genital surgery (NHS England, 2024).

Critical exclusions affect nonbinary patients and those seeking specific outcomes. Nullification surgery—penectomy plus orchiectomy without vaginoplasty—is not offered on NHS, nor is standalone penectomy. Breast augmentation, facial feminisation surgery, voice surgery, and most hair removal also fall outside commissioning. For readers of this book seeking nulloplasty specifically, the NHS pathway offers no direct route; the only options are private surgery in the UK or abroad.

Waiting Times for Surgery#

After completing the assessment process—itself a multi-year journey—patients face additional waits for surgery. Feminising genital surgery waits currently run two to three years from approved referral to operation date (NHS England, 2025). Masculinising surgery waits are substantially longer and less predictable, with the commissioning failures between 2020 and 2021 creating a backlog that continues to affect current wait times.

As of late 2025, the total timeline from initial GIC referral to completed genital surgery realistically spans eight to twelve years for most patients accessing the NHS pathway without supplementary private care (TransActual, 2025).

Devolved Nations: Scotland, Wales, and Northern Ireland#

While the four-nations surgical contract means all UK residents access the same surgical services, pathways to reach those services vary by nation.

Scotland#

NHS Scotland operates its own GICs through a regional catchment system rather than England's patient-choice model (NHS Scotland, 2024). Edinburgh's Chalmers GIC has reduced waits to approximately 584 days—about nineteen months—representing a 43% reduction since 2021. Glasgow Sandyford, serving the largest catchment area, shows waits of seven years and one month for adults and six years and one month for young people. As of March 2024, 5,640 people were waiting across Scottish gender services, with 75% waiting up to three years and 25% waiting longer.

Despite periodic characterisation as offering a more progressive approach, Scotland now operates under the same constraints as the rest of the UK. The Gender Recognition Reform (Scotland) Bill, which would have lowered the GRC age to sixteen and removed medical diagnosis requirements, was blocked by the UK Government in January 2023 using Section 35 of the Scotland Act—its first-ever use (Scottish Government, 2023). Following the April 2025 Supreme Court ruling on biological sex, the Scottish Government confirmed it has "no plans to bring the bill back" (Scottish Government, 2025). Scottish surgery access remains through the four-nations contract, with the Scottish Government currently scoping feasibility of providing surgery domestically.

Wales#

The Welsh Gender Service, based in Cardiff, offers twenty-month waits—significantly shorter than English GICs—for initial appointments (NHS Wales, 2024). However, it accepts GP referrals only (no self-referral) and surgical access follows the same four-nations pathway. Contact the Welsh Gender Service at 029 2183 6612 or through NHS Wales.

Northern Ireland#

Northern Ireland presents the most challenging situation. Brackenburn Clinic in Belfast sees patients referred in October 2017, no surgery is performed locally, and all surgical care requires referral to England (HSC Northern Ireland, 2024). The service closed to new referrals for several years before reopening and operates with severe staffing constraints.

Private Healthcare Options#

Private gender assessment services have proliferated to address NHS failures, though they vary significantly in approach, cost, and acceptance by surgeons and NHS services.

Private Assessment Providers#

GenderCare, founded by Dr Stuart Lorimer and Dr Penny Lenihan, commands strong credibility within the UK system. Approximately 70% of GPs are willing to enter shared care arrangements based on GenderCare assessments, and their recommendations are widely accepted by both NHS and private surgeons (GenderCare, 2024). Initial assessment costs £300 to £450 with six to nine month waits.

Gender Plus, now CQC-approved to prescribe hormones for over-sixteens, charges £325 per hour for assessments (Gender Plus, 2024). Their prescriptions and assessments have broad acceptance among UK providers.

GenderGP operates an informed consent model at lower cost—£195 starter fee plus £30 monthly subscription—but faces significant GP reluctance to enter shared care due to previous regulatory issues (GenderGP, 2024). While this service offers faster and more affordable access to hormones, patients may face challenges if they later need NHS services or GP support.

The Bridge Between Private and NHS Care#

Private diagnosis can theoretically support NHS surgical access, but the pathway is inconsistent. NHS GICs may require their own assessments even with private diagnosis—Leeds GIC explicitly states that "everyone being seen as a new patient requires assessment appointments, even if you have received a diagnosis privately" (Leeds GIC, 2024).

A more practical strategy involves simultaneous engagement: referring to NHS GIC immediately upon recognising the need for surgical care (accepting the multi-year wait), using private services to obtain diagnosis and begin hormone therapy, establishing shared care with a GP for ongoing hormone prescriptions, and presenting this history when eventually seen by NHS services. This approach may expedite the assessment phase but does not bypass it entirely.

Private assessments are accepted for Gender Recognition Certificate applications, which in turn can streamline NHS surgical referral—GRC holders require only a single medical opinion rather than two letters (GOV.UK, 2024).

Private Surgery Costs#

Private surgery costs vary dramatically by procedure and surgeon. Vaginoplasty ranges from £15,000 to £30,000 in the UK, with orchiectomy at £3,000 to £6,000 and vulvoplasty at £9,500 to £12,000 (The London Transgender Clinic, 2024). Masculinising procedures cost substantially more: metoidioplasty runs £10,000 to £30,000 or more depending on complexity, while multi-stage phalloplasty ranges from £25,000 to £60,000 or more.

A complete private pathway including assessments, hormone monitoring, hair removal, and surgery typically totals £18,000 to £35,000 for feminising procedures and £35,000 to £80,000 or more for complete phalloplasty.

Insurance Coverage#

Private health insurance rarely covers gender-affirming procedures. Individual policies from Bupa, AXA, and Aviva typically exclude gender-affirming surgery entirely (TransActual, 2024). Corporate group insurance sometimes offers coverage—Bupa's corporate plans include a two-tier gender dysphoria proposition where Tier 2 covers full transition including surgery—but individual purchasers cannot access this.

Self-funding through medical finance, crowdfunding (commonly through GoFundMe with the #TransCrowdFund hashtag), or charitable grants represents reality for most private patients. Action for Trans Health provides grants typically ranging from £100 to £600, with a maximum of £1,500 (Action for Trans Health, 2024).

Accessing Care Abroad as a UK Resident#

Going abroad offers an increasingly common alternative for UK residents facing years-long waits and procedures not covered by the NHS.

Thailand#

Thailand provides vaginoplasty at £6,500 to £18,000—compared to UK private prices of £15,000 to £30,000—with surgeons including Dr Chettawut and the Suporn Clinic team offering decades of experience (Chettawut Plastic Surgery Center, 2024; Suporn Clinic, 2024). Total costs including flights, accommodation for the required three-week minimum stay, and aftercare typically remain below UK private prices even accounting for exchange rate fluctuations. Thai surgeons generally require patients to have been on hormone therapy for at least twelve months and to provide letters from qualified mental health professionals.

Serbia#

Dr Miroslav Djordjevic is world-renowned for metoidioplasty and phalloplasty, attracting patients from across Europe and beyond (Belgrade Center for Genital Reconstructive Surgery, 2024). Serbian prices for masculinising surgery are substantially lower than UK equivalents, though the total cost including multiple trips for staged procedures and extended recovery stays should be factored carefully.

Belgium and Turkey#

Belgium offers high-quality surgical care at costs between UK and Thai prices, with the advantage of relative geographic proximity and EU medical standards (Ghent University Hospital, 2024). Turkey has emerged as a hub for facial feminisation surgery specifically, with costs significantly below UK and US prices, though quality varies considerably between providers and thorough vetting is essential.

Considerations for International Surgery#

Aftercare coordination with UK services presents the primary challenge for international surgery. Complications requiring attention after returning to the UK may be managed by providers unfamiliar with the specific techniques used abroad. Establishing a relationship with a sympathetic GP and, if possible, a UK-based surgeon willing to provide follow-up care before traveling is strongly advisable.

Travel insurance that explicitly covers complications from elective surgery abroad is essential—many standard policies exclude such coverage. Read policy documents carefully and consider medical tourism-specific insurance products.

The Regulatory and Legal Environment#

UK practice maintains a gatekeeping model at odds with WPATH SOC8's shift toward patient autonomy. The requirement for psychiatric assessment, multiple letters, and demonstration periods for hormone therapy and social transition reflects an approach that views gender dysphoria treatment as requiring external validation rather than supported informed consent (Coleman et al., 2022).

GMC Guidance#

The General Medical Council takes a more neutral stance than NHS commissioning specifications, emphasising shared decision-making and patient autonomy while acknowledging that most transgender hormone treatments are "off-label" (GMC, 2024). The GMC permits bridging prescriptions by GPs when patients are self-medicating or likely to self-medicate, intended to mitigate risk of self-harm. However, practical GP implementation varies enormously.

Age Requirements#

The minimum age for NHS genital surgery is seventeen years, not eighteen as commonly believed, though private providers typically require eighteen years (NHS England, 2024). Top surgery (mastectomy) has no specific minimum age in NHS commissioning but is rarely performed on patients under eighteen. The Cass Review's recommendations do not directly apply to surgery—which was never available to minors—but have created downstream effects on hormone access for under-25s that affect the twelve-month hormone requirement for surgical eligibility.

The April 2025 Supreme Court Ruling#

The April 2025 Supreme Court ruling in For Women Scotland v The Scottish Ministers represents the most significant legal development affecting trans people in the UK in decades. The Court determined that "man," "woman," and "sex" in the Equality Act 2010 refer to biological sex (UK Supreme Court, 2025). Trans women with Gender Recognition Certificates cannot be legally recognised as women for Equality Act purposes, enabling exclusion from single-sex spaces including hospital wards.

The EHRC chair stated the NHS would "have to change" its policy of treating trans patients according to declared gender (EHRC, 2025). The practical implications for surgical recovery—which historically occurs in single-sex wards—remain unclear but potentially significant. Patients should discuss ward placement with their surgical team before admission and advocate clearly for their needs while recognising that institutional policies may be in flux.

The Cass and Levy Reviews#

The Cass Review, published April 2024, formally addresses only children and young people's services but has generated significant ripple effects into adult care (Cass, 2024). Its characterisation of the evidence base for gender-affirming care as "insufficient" and criticism of WPATH guidelines has provided justification for GPs and other providers to withdraw from trans healthcare provision.

The Levy Review of adult gender identity services, published December 2025, documented failures across the system while proposing twenty recommendations focused on operational improvements (Levy, 2025). Key recommendations include creating a national waiting list by April 2026, ending self-referral (requiring GP referral instead), and raising the referral threshold to age eighteen. Notably absent are recommendations addressing fundamental capacity constraints, commissioning failures for masculinising surgery, or the gap between NHS requirements and international standards of care.

Advocacy and Support Organisations#

Patient advocacy organisations and peer support networks have become essential infrastructure—filling gaps the healthcare system cannot or will not address.

TransActual coordinates the Trans Healthcare Coalition and has undertaken legal action including the (unsuccessful) challenge to the puberty blocker ban. The organisation gave evidence to the Commission on Human Medicines and advocates for patients affected by masculinising surgery commissioning failures. Contact through transactual.org.uk.

Gendered Intelligence operates a dedicated support line for adults affected by waiting lists, providing peer support and practical guidance for navigating the system. Contact through genderedintelligence.co.uk or their support line.

Stonewall, as the largest LGBTQ+ charity, runs the TRANSforming Futures programme providing research and funding across ten partner organisations (Stonewall, 2024). Their resources and advocacy efforts address systemic barriers to trans healthcare.

Mermaids supports gender-diverse young people and their families, with a helpline at 0808 801 0400 (Mermaids, 2024).

Legal Advocacy#

Legal advocacy continues through Leigh Day, representing trans men affected by commissioning failures for masculinising surgery (Leigh Day, 2024). The Good Law Project partnered with TransActual on the puberty blocker challenge and continues monitoring Levy Review implementation.

International human rights bodies have expressed concern about the UK's trajectory. The UN Independent Expert on Sexual Orientation and Gender Identity cited "toxic transphobic political discourse" in the UK, while Human Rights Watch called the Supreme Court ruling "severely regressive" (Human Rights Watch, 2025; OHCHR, 2024).

Accessing UK Care as a US Resident#

For American readers considering the UK for surgical care, the landscape presents significant challenges that generally make it a less attractive option compared to other international destinations.

Visa and Entry Requirements#

US citizens can enter the UK for up to six months without a visa for medical treatment, though you may be asked to provide evidence of your appointment and ability to fund your stay at the border (GOV.UK, 2024). For extended stays or multiple trips for staged procedures, consult UK immigration guidance carefully.

Cost Comparison#

UK private surgery costs are comparable to or higher than US out-of-pocket costs for most procedures, without the offset of potential insurance coverage that exists for some US patients. Combined with transatlantic travel expenses and accommodation for recovery periods, the UK offers limited cost advantage over domestic US options.

Wait Times#

Private UK surgeons have their own waitlists, typically ranging from six months to two years depending on surgeon and procedure (The London Transgender Clinic, 2024). While shorter than NHS waits, these are comparable to or longer than waits for high-volume US surgeons.

When UK Care Might Make Sense#

The UK may be worth considering for American patients if you have specific interest in a particular UK surgeon's technique, family or support network in the UK making extended stays more feasible, or existing relationships with UK healthcare providers. However, for most American readers, destinations like Thailand, Mexico, or European countries with lower costs and comparable or better expertise will offer more practical options. See the other country guides in this section for comprehensive guidance on those destinations.

Given the systemic barriers documented throughout this guide, practical strategies for navigating the UK system require parallel pathways and proactive planning.

Immediate Actions#

Refer yourself to an NHS GIC immediately upon recognising you may want surgical care, regardless of how far away surgery feels. The wait begins only when you're on the list. If you're uncertain about your needs or timeline, refer anyway—you can withdraw later, but you cannot recover years spent not waiting.

Research private assessment options and consider whether beginning that pathway while waiting for NHS makes sense for your circumstances. The investment in private assessment may be recovered through earlier access to hormones and, potentially, expedited NHS surgical referral.

If you're employed with access to corporate health insurance, investigate whether your plan includes trans healthcare coverage. Some corporate Bupa plans cover gender-affirming surgery that individual policies exclude.

Documentation Practices#

Maintain comprehensive records of your gender history, medical care, and system interactions. Document dates of referrals, appointments, and communications with healthcare providers. This documentation supports appeals if services are denied and demonstrates your established history if you later seek private care or care abroad.

Request copies of all letters, assessments, and medical records. Under UK data protection law, you have the right to access your medical records within one month of request, and providers cannot charge more than a reasonable fee for copies (ICO, 2024).

Building Provider Relationships#

Identify a GP willing to support your care, including entering shared care arrangements if you access private assessment services. Not all practices are willing—be prepared to register with a different practice if necessary. Trans-friendly GP lists circulated within community networks can help identify supportive providers in your area.

Consider establishing contact with a UK surgeon who might provide emergency or follow-up care if you pursue surgery abroad. Even if you ultimately have surgery in Thailand or elsewhere, having a UK provider familiar with your case can be invaluable if complications arise after your return.

Community Connection#

Connect with trans community networks and support groups, both for practical information exchange and emotional support through what can be an exhausting process. Online communities including Reddit's r/transgenderUK, various Discord servers, and Facebook groups provide real-time information about wait times, provider experiences, and system navigation strategies.

Peer support from people who have navigated the same system offers insights that official guidance cannot provide. Community knowledge about which GICs are more efficient, which private providers are most reliable, and which strategies have worked for others can significantly improve your experience.

Conclusion: A System in Crisis#

The UK's approach to gender-affirming bottom surgery access has reached a crisis point that the December 2025 Levy Review officially acknowledged but did not propose to fundamentally address (Levy, 2025). The review documented over 40,000 patients waiting, eight to nine year surgery waits, and "inconsistent data collection" making outcomes "impossible to understand"—yet its recommendations focus on operational efficiency rather than capacity expansion or pathway reform.

The core tension remains unresolved: international standards have shifted toward informed consent and reduced gatekeeping while UK practice maintains multiple psychiatric assessments, mandatory waiting periods, and prerequisites that WPATH no longer recommends (Coleman et al., 2022). The four-nations surgical commissioning structure, already demonstrated as fragile, supports demand through only a handful of centres.

For individuals navigating this system in 2025 and 2026, the practical reality involves multi-year NHS waits regardless of nation, private options requiring £20,000 to £80,000 out-of-pocket with limited insurance coverage, an uncertain legal environment following the Supreme Court ruling, and decreasing GP willingness to participate in shared care. Patient advocacy organisations and peer support networks have become essential infrastructure—filling gaps the healthcare system cannot or will not address.

The system does not require minor adjustments. It requires recognition that current capacity serves only a fraction of demand, that the gatekeeping model itself may constitute a barrier to care rather than a pathway toward it, and that UK residents deserve access that meets international standards of care. Until that recognition translates into policy change, individual navigation strategies, community support, and—for many—looking beyond UK borders will remain necessary survival tools.

Reflection Questions#

If you're considering accessing care in the UK, what is your realistic timeline? Have you factored in multi-year waits for NHS care, or are private/international options more practical for your circumstances?
What support systems—medical, social, financial—do you have in place for what may be a very long journey? How might you strengthen those systems before they're tested by years of waiting?
If you're a UK resident who has already been waiting, what parallel pathways might you explore? Private assessment? Care abroad? What resources would you need to pursue those options?
How do you balance hope for systemic improvement with practical planning for the system as it currently exists? What would it mean to "prepare for the worst while hoping for the best" in your specific situation?
What role might community connection and peer support play in sustaining you through a potentially years-long process? What communities are you already connected to, and what communities might you seek out?

References#

Action for Trans Health. (2024). Grants. https://actionfortranshealth.org.uk/grants/

Belgrade Center for Genital Reconstructive Surgery. (2024). About us. https://www.genitalsurgerybelgrade.com/

Cass, H. (2024). Independent review of gender identity services for children and young people: Final report. NHS England. https://cass.independent-review.uk/home/publications/final-report/

Chettawut Plastic Surgery Center. (2024). Gender reassignment surgery. https://www.chet-plasticsurgery.com/

Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., ... & Arcelus, J. (2022). Standards of care for the health of transgender and gender diverse people, version 8. International Journal of Transgender Health, 23(S1), S1–S259. https://doi.org/10.1080/26895269.2022.2100644

EHRC. (2025, April). Statement on Supreme Court judgment in For Women Scotland Ltd v The Scottish Ministers. Equality and Human Rights Commission. https://www.equalityhumanrights.com/

Gender Construction Kit. (2025). Wait times. https://genderkit.org.uk/resources/wait-times/

GenderCare. (2024). Our services. https://gendercare.co.uk/

GenderGP. (2024). How it works. https://www.gendergp.com/

Gender Plus. (2024). Services. https://genderplus.com/

Ghent University Hospital. (2024). Center for Sexology and Gender. https://www.uzgent.be/

GMC. (2024). Trans healthcare. General Medical Council. https://www.gmc-uk.org/ethical-guidance/ethical-hub/trans-healthcare

GOV.UK. (2024). Apply for a Gender Recognition Certificate. https://www.gov.uk/apply-gender-recognition-certificate

GOV.UK. (2024). Visit the UK as a Standard Visitor. https://www.gov.uk/standard-visitor

HSC Northern Ireland. (2024). Gender identity services. Health and Social Care Northern Ireland. https://online.hscni.net/

Human Rights Watch. (2025, April). UK: Supreme Court ruling undermines trans rights. https://www.hrw.org/

ICO. (2024). Your right of access. Information Commissioner's Office. https://ico.org.uk/your-data-matters/your-right-of-access/

Leeds GIC. (2024). Frequently asked questions. Leeds and York Partnership NHS Foundation Trust. https://www.leedsandyorkpft.nhs.uk/

Leigh Day. (2024). Trans healthcare legal action. https://www.leighday.co.uk/

Levy, D. (2025). Independent review of gender identity services for adults. NHS England. https://www.england.nhs.uk/

Mermaids. (2024). Support. https://mermaidsuk.org.uk/

NHS England. (2024). Gender dysphoria services. https://www.england.nhs.uk/commissioning/spec-services/npc-crg/gender-dysphoria-clinical-programme/

NHS England. (2025). Gender identity services statistics. https://www.england.nhs.uk/

NHS Scotland. (2024). Gender identity services. https://www.nhsinform.scot/

NHS Wales. (2024). Welsh Gender Service. https://cavuhb.nhs.wales/

OHCHR. (2024). UK: UN expert concerned about toxic anti-trans discourse. Office of the High Commissioner for Human Rights. https://www.ohchr.org/

RCGP. (2024, October). Position statement on gender identity. Royal College of General Practitioners. https://www.rcgp.org.uk/

Scottish Government. (2023). Gender Recognition Reform (Scotland) Bill. https://www.gov.scot/

Scottish Government. (2024). Gender identity healthcare: Action plan. https://www.gov.scot/

Scottish Government. (2025). Statement following Supreme Court judgment. https://www.gov.scot/

Stonewall. (2024). TRANSforming Futures. https://www.stonewall.org.uk/

Suporn Clinic. (2024). Services. https://www.supornclinic.com/

The London Transgender Clinic. (2024). Surgery. https://www.thelondontransgenderclinic.uk/

TransActual. (2023). Trans healthcare commissioning briefing. https://transactual.org.uk/

TransActual. (2024). Trans healthcare resources. https://transactual.org.uk/healthcare-trans/

TransActual. (2025). Waiting times crisis. https://transactual.org.uk/

UK Supreme Court. (2025). For Women Scotland Ltd v The Scottish Ministers [2025] UKSC 16. https://www.supremecourt.uk/